On 05 de nov. de 2025, STE reported earnings of 2.47 USD per share (EPS) for Q2 26, beating the estimate of 2.37 USD, resulting in a 4.03% surprise. Revenue reached 1.46 bilhão, compared to an expected 1.45 bilhão, with a 1.01% difference. The market reacted with a +6.94% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analistas forecast an EPS of 2.55 USD, with revenue projected to reach 1.50 bilhão USD, implying an aumentar of 3.24% EPS, and aumentar of 2.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
What were STERIS plc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, STERIS plc reported EPS of $2.47, beating estimates by 4.03%, and revenue of $1.46B, 1.01% above expectations.
How did the market react to STERIS plc's Q2 2026 earnings?
The stock price moved up 6.94%, changed from $243.18 before the earnings release to $260.06 the day after.
When is STERIS plc expected to report next?
The next earning report is scheduled for 03 de fev. de 2026.
What are the forecasts for STERIS plc's next earnings report?
Based on 9
analistas, STERIS plc is expected to report EPS of $2.55 and revenue of $1.50B for Q3 2026.